Abingdon Health plc (ABDX.L)
Abingdon Health plc engages in the development, manufacture, and distribution of diagnostic devices worldwide. The company offers AbC-19 Rapid Test, a COVID-19 IgG rapid antibody test; nucleic acid lateral flow immunoassays; PCRD and PCRD FLEX, nucleic acid lateral flow tests used for rapid readouts post isothermal amplification; Abingdon Simply Test, a range of self-tests; and 2019-nCoV Antigen Test, a rapid lateral flow test for the qualitative detection of antigens to SARS-CoV-2. It also provides AppDx, a customizable image capturing technology that transforms a smartphone into a self-sufficient and standalone lateral-flow reader. In addition, the company provides contract manufacturing, nucleic acid lateral flow test customization, and lateral flow development and manufacturing services. Further, it provides consultancy services to businesses in the healthcare technology sector. The company has a collaboration and co-marketing agreement with Abcam plc. Abingdon Health plc was incorporated in 2008 and is headquartered in York, the United Kingdom.
Company Info
| ISIN | GB00BLF79J41 |
|---|---|
| Sector | Healthcare |
| Industry | Diagnostics & Research |
Highlights
| Market Cap | £13.69M |
|---|---|
| EPS | -£0.06 |
| Revenue (TTM) | £2.24M |
| Gross Profit (TTM) | -£3.59M |
| EBITDA (TTM) | -£7.93M |
| Year Range | £3.60 - £18.50 |
Share Price Chart
Loading data...
Performance
The chart shows the growth of an initial investment of £10,000 in Abingdon Health plc, comparing it to the performance of the S&P 500 index or another benchmark. All prices have been adjusted for splits and dividends.
Compare to other instruments
Return
Abingdon Health plc had a return of 65.38% year-to-date (YTD) and 53.57% in the last 12 months.
| Period | Return | Benchmark |
|---|---|---|
| 1 month | 2.38% | 0.15% |
| 6 months | 126.32% | 8.48% |
| Year-To-Date | 65.38% | 10.13% |
| 1 year | 53.57% | 5.87% |
| 5 years (annualized) | -56.26% | 7.57% |
| 10 years (annualized) | N/A | N/A |
Monthly Returns Heatmap
| Jan | Feb | Mar | Apr | May | Jun | Jul | Aug | Sep | Oct | Nov | Dec | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2023 | -0.00% | 8.70% | 28.00% | 31.25% | 14.29% | -18.75% | 10.26% |
Risk-Adjusted Performance
This table presents a comparison of risk-adjusted performance metrics for Abingdon Health plc (ABDX.L) and S&P 500 (^GSPC). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.
| Sharpe ratio | Sortino ratio | Omega ratio | Calmar ratio | Ulcer Index | |
|---|---|---|---|---|---|
ABDX.L Abingdon Health plc | 0.49 | ||||
^GSPC S&P 500 | 0.70 |
Dividend History
Drawdowns Chart
The Drawdowns chart displays portfolio losses from any high point along the way.
Worst Drawdowns
The table below shows the maximum drawdowns of the Abingdon Health plc. A maximum drawdown is an indicator of risk. It shows a reduction in portfolio value from its maximum due to a series of losing trades.
The maximum drawdown since January 2010 for the Abingdon Health plc is 97.01%, recorded on Dec 16, 2022. The portfolio has not recovered from it yet.
Depth | Start | To Bottom | Bottom | To Recover | End | Total |
|---|---|---|---|---|---|---|
| -97.01% | Jan 27, 2021 | 478 | Dec 16, 2022 | — | — | — |
| -11.79% | Dec 18, 2020 | 21 | Jan 20, 2021 | 3 | Jan 25, 2021 | 24 |
Volatility Chart
The current Abingdon Health plc volatility is 9.78%, representing the average percentage change in the investments's value, either up or down over the past month. The chart below shows the rolling one-month volatility.